Prostate Cancer - Results from #19980

Pharmacologic inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer - Abstract August 5, 2014

Increased risk of pneumonia in patients receiving gonadotropin-releasing hormone agonists for prostate cancer - Abstract August 5, 2014

The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy - Abstract August 5, 2014

Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancer - Abstract August 5, 2014

MR-sequences for prostate cancer diagnostics: Validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy - Abstract August 5, 2014

Pentafecta outcomes after robot-assisted laparoscopic radical prostatectomy: First 100 cases in Latinoamerican Hospital - Abstract August 5, 2014

PSA velocity: A systematic review of clinical applications - Abstract August 5, 2014

Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial - Abstract August 5, 2014

An investigation of the effects from a urethral warming system on temperature distributions during cryoablation treatment of the prostate: A phantom study - Abstract August 5, 2014

Combination of lidocaine suppository and periprostatic nerve block during transrectal prostate biopsy: A prospective randomized trial - Abstract August 5, 2014

Phase II study of single agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen - Abstract August 5, 2014

The relationship between the extent of extraprostatic extension and survival following radical prostatectomy - Abstract August 5, 2014

Psychosocial trajectories of men monitoring prostate-specific antigen levels following surgery for prostate cancer - Abstract August 5, 2014

The use of luteinizing hormone-releasing hormone analogues is still an indispensable element of therapy in castrate-resistant prostate cancer - Abstract August 4, 2014

Healthcare providers' perspectives of the supportive care needs of men with advanced prostate cancer - Abstract August 4, 2014

Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy - Abstract August 4, 2014

Perceptions of prostate cancer screening controversy and informed decision making: Implications for development of a targeted decision aid for unaffected male first-degree relatives - Abstract August 4, 2014

Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancer - Abstract August 4, 2014

Impact of race in a predominantly African-American population of patients with low/intermediate risk prostate cancer undergoing radical prostatectomy within an equal access care institution - Abstract August 4, 2014

Real-time elastography of the prostate - Abstract August 4, 2014

Page 1000 of 1435